PLK2 Antikörper (C-Term)
Kurzübersicht für PLK2 Antikörper (C-Term) (ABIN2337662)
Target
Alle PLK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo Rt
-
Produktmerkmale
- PLK2 (PLK-2, SNK, hPlk2, hSNK, Polo-like kinase 2, Serum-inducible kinase, Polo-like kinase 2 (Drosophila), Serine/threonine-protein kinase SNK, Proprotein convertase, subtitisin/kexin-type, 9)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminal of human PLK2, different from the related mouse sequence by one amino acid, and from the related rat sequence by two amino acids.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 4°C/-20°C
-
-
- PLK2 (Polo-Like Kinase 2 (PLK2))
-
Andere Bezeichnung
- PLK2
-
UniProt
- Q9NYY3
Target
-